Clustering data with hclust algorithm for Statin Immuno-Metabolomics in Asthma (part II) (Study ST000844)
Reversed phase POSITIVE ION MODE (Analysis AN001367)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 |
|---|---|---|---|---|---|---|---|---|---|---|
| PGF2a EA | ME224534 | NA | 0.68 | 5.18 | 2.08 | 0.36 | 0.14 | 0.22 | 0.43 | 0.65 |
| 15-HETE EA | ME224535 | 0.45 | 2.02 | 1.96 | 1.00 | NA | 0.20 | 0.58 | 0.16 | 0.08 |
| PEA | ME224525 | 0.83 | 0.61 | 1.18 | 0.81 | 1.30 | 0.35 | 0.88 | 0.77 | 2.62 |
| SEA | ME224526 | 0.90 | 0.66 | 1.21 | 0.99 | 1.31 | 0.75 | 0.77 | 0.78 | 1.86 |
| NO-Gly | ME224536 | 0.96 | 0.98 | 0.45 | 0.87 | 1.22 | 1.55 | 1.41 | 1.22 | 0.95 |
| DHEA | ME224533 | 1.12 | 0.95 | 0.71 | 1.00 | 1.16 | 1.15 | 1.07 | 1.07 | 1.00 |
| Dihomo GLA EA | ME224530 | 1.37 | 1.03 | 0.85 | 0.96 | 0.74 | 1.05 | 1.15 | 0.90 | 0.71 |
| AEA | ME224531 | 1.36 | 1.07 | 0.58 | 1.05 | 0.73 | 1.05 | 1.05 | 1.30 | 0.80 |
| DEA | ME224532 | 1.34 | 1.02 | 0.70 | 1.05 | 0.88 | 1.11 | 0.84 | 1.14 | 0.84 |
| OEA | ME224527 | 1.19 | 0.88 | 0.70 | 1.31 | 0.70 | 1.47 | 1.00 | 1.24 | 0.75 |
| aLEA | ME224529 | 1.37 | 0.94 | 0.54 | 1.48 | 0.74 | 0.85 | 1.24 | 1.29 | 0.71 |
| LEA | ME224528 | 1.18 | 0.90 | 0.59 | 1.60 | 0.81 | 1.11 | 1.10 | 1.27 | 0.77 |
Factors:
| F1 | Treatment:Control | Day:Day 0 |
| F2 | Treatment:Control | Day:Day 12 |
| F3 | Treatment:Control | Day:Day 8 |
| F4 | Treatment:Pravastatin | Day:Day 0 |
| F5 | Treatment:Pravastatin | Day:Day 12 |
| F6 | Treatment:Pravastatin | Day:Day 8 |
| F7 | Treatment:Simvastatin | Day:Day 0 |
| F8 | Treatment:Simvastatin | Day:Day 12 |
| F9 | Treatment:Simvastatin | Day:Day 8 |
